✦ LIBER ✦

295 Capecitabine plus irinotecan (CAPIRI) vs capecitabine plus oxaliplatin (CAPOX) as first-line therapy of advanced colorectal cancer (ACRC): updated results of a randomized phase II trial

✍ Scribed by A. Grothey; K. Jordan; O. Kellner; C. Constantin; G. Dietrich; H. Kroening; L. Mantovani; C. Schlichting; H. Forstbauer; H.J. Schmoll

Book ID: 118620470
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 326 KB
Volume: 1
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(03)90328-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of a Phase II Trial of Cetuximab

Results of a Phase II Trial of Cetuximab plus Capecitabine/Irinotecan as First-Line Therapy for Patients with Advanced and/or Metastatic Colorectal Cancer

✍ Thomas Cartwright; Paul Kuefler; Allen Cohn; William Hyman; Maury Berger; Donald 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 144 KB

A phase II study of capecitabine plus 3-

A phase II study of capecitabine plus 3-weekly oxaliplatin as first-line therapy for patients with advanced gastric cancer

✍ Park, Y H; Kim, B-S; Ryoo, B-Y; Yang, S H 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 104 KB

Cetuximab Plus Capecitabine and Irinotec

Cetuximab Plus Capecitabine and Irinotecan Compared With Cetuximab Plus Capecitabine and Oxaliplatin As First-Line Treatment for Patients With Metastatic Colorectal Cancer: AIO KRK-0104--A Randomized Trial of the German AIO CRC Study Group

✍ Moosmann, N.; von Weikersthal, L. F.; Vehling-Kaiser, U.; Stauch, M.; Hass, H. G 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 169 KB

277 Combination of irinotecan and capeci

277 Combination of irinotecan and capecitabine as first line treatment in advanced colorectal cancer (ACC): results of a phase II multicenter trial

✍ C.J.A. Punt; J.W.R. Nortier; W.W. ten Bokkel Huinink; S. Falk; D.J. Richel; T. M 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 168 KB

Capecitabine in combination with oxalipl

Capecitabine in combination with oxaliplatin as first line therapy for patients (pts) with advanced or metastatic colorectal cancer (ACRC): preliminary results of an international multicenter phase II study

✍ Twelves, C.; Butts, C.; Cassidy, J.; Conroy, Th.; DeBraud, F.; Díaz-Rubio, E.; F 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 170 KB

A randomized phase II trial to elucidate

A randomized phase II trial to elucidate the efficacy of capecitabine plus cisplatin (XP) and S-1 plus cisplatin (SP) as a first-line treatment for advanced gastric cancer: XP ascertainment vs. SP randomized PII trial (XParTS II)

✍ Akira Tsuburaya, Satoshi Morita, Yasuhiro Kodera, Michiya Kobayashi, Kohei Shita 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 157 KB